Detalles de la búsqueda
1.
Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Hepatol Res
; 54(6): 562-574, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38133587
2.
Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
J Gastroenterol Hepatol
; 2024 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494668
3.
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.
J Viral Hepat
; 30(4): 297-302, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36648382
4.
Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors.
Hepatol Res
; 53(5): 450-459, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36626292
5.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741640
6.
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.
Invest New Drugs
; 40(2): 392-402, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34586531
7.
JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis.
Hepatol Res
; 50(7): 775-790, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298527
8.
Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient.
Hepatol Res
; 50(4): 524-531, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883166
9.
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials.
Hepatol Res
; 50(10): 1109-1117, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614468
10.
Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium.
J Hepatol
; 71(1): 143-152, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30898581
11.
Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Dig Dis
; 37(3): 247-254, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625487
12.
Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents.
Hepatol Res
; 49(5): 500-511, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30623518
13.
Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma.
Hepatol Res
; 49(12): 1466-1474, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31261448
14.
Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.
Clin Gastroenterol Hepatol
; 2018 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29933096
15.
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Gastroenterology
; 152(6): 1383-1394, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28163062
16.
Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.
Liver Int
; 38(9): 1552-1561, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29297980
17.
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.
Hepatol Res
; 48(6): 442-450, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29278654
18.
Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C.
J Hepatol
; 67(5): 933-939, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28627363
19.
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
J Med Virol
; 89(7): 1241-1247, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28036111
20.
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin.
Hepatol Res
; 47(11): 1212-1218, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28128521